Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | 066 | Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor | 3gwt | 0.00794 |
2 | pil | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilast | 1xm4 | 0.041 |
3 | zg2 | Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine inhibitor | 3o57 | 0.0794 |
4 | rof | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilast | 1xmu | 0.84 |
5 | 20a | Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor | 3d3p | 3.16 |
6 | sk4 | Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor | 3frg | 3.98 |
7 | z72 | Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor | 3ly2 | 5 |
8 | qpc | Crystal structure of phosphodiesterase 4B in complex with compound 10f | 3wd9 | 8.3 |
9 | nvw | Crystal structure of phosphodiesterase 4B in complex with compound 31e | 3w5e | 11 |
10 | cio | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast | 1xlx | 25 |
11 | 19t | Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33 | 4myq | 32 |
12 | rol | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Rolipram | 1xmy | 50.12 |
13 | hbt | Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibitor | 3hmv | 50.12 |
14 | 2o5 | PDE4 catalytic domain | 4nw7 | 237 |
15 | rol | Crystal structure of PDE4B2B complexed with Rolipram (R & S) | 1ro6 | 350 |
16 | rol | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Rolipram | 1xn0 | 570 |
17 | fil | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast | 1xlz | 960 |
18 | vdn | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil | 1xot | 3800 |
19 | via | Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil | 1xos | 2e+004 |